Abstract: The application discloses a method for the treatment of Heliobacter infection in a mammalian host, which comprises administration to said infected host of an immunologically effective amount of one or more Heliobacter antigen(s), optionally in association with a mucosal adjuvant.
Type:
Grant
Filed:
August 18, 1995
Date of Patent:
February 16, 1999
Assignees:
CSL Limited, The Univ. of New South Wales